Elevated serum neurofilament light chain levels are associated with hepatic encephalopathy in patients with cirrhosis

No abstract is available for this paper.

• Publication year

  2024

• Venue

  Metabolic brain disease

• Publication date

  2024-07-12

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s11011-024-01381-0PMID 38995495
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Elevated serum levels of glial fibrillary acidic protein are associated with covert hepatic encephalopathy in patients with cirrhosis

  2023cited by this paper
• Diabetes and cirrhosis: Current concepts on diagnosis and management

  2023cited by this paper
• Neurofilament Light Chain Protein in Plasma and Extracellular Vesicles Is Associated with Minimal Hepatic Encephalopathy and Responses to Rifaximin Treatment in Cirrhotic Patients

  2023cited by this paper
• Hepatic encephalopathy

  2022cited by this paper
• Diabetes mellitus is associated with higher serum neurofilament light chain levels in the general U.S. population.

  2022cited by this paper
• The multifaceted role of neurofilament light chain protein in non-primary neurological diseases

  2022cited by this paper
• Heretical thoughts into Hepatic Encephalopathy.

  2022cited by this paper
• Hepatic Encephalopathy: From Metabolic to Neurodegenerative

  2021cited by this paper
• Liver cirrhosis.

  2021cited by this paper
• Determination of Turkish norms of psychometric tests for diagnosing minimal hepatic encephalopathy and proposal of a high sensitive screening test battery

  2021cited by this paper
• Exercise, diet and stress as modulators of gut microbiota: Implications for neurodegenerative diseases.

  2020cited by this paper
• Serum neurofilament light in atrial fibrillation: clinical, neuroimaging and cognitive correlates

  2020cited by this paper
• Hepatic encephalopathy: Novel insights into classification, pathophysiology and therapy.

  2020cited by this paper
• Different Clinical Contexts of Use of Blood Neurofilament Light Chain Protein in the Spectrum of Neurodegenerative Diseases

  2020cited by this paper
• Psychological Burden of Hepatic Encephalopathy on Patients and Caregivers

  2020cited by this paper
• Pathophysiology of Hepatic Encephalopathy.

  2020cited by this paper
• Minimal Hepatic Encephalopathy.

  2020cited by this paper
• Neurofilament light chain as a biomarker in neurological disorders

  2019cited by this paper
• Burden of liver diseases in the world.

  2019cited by this paper
• Neurological Complications Occurring After Liver Transplantation: Role of Risk Factors, Hepatic Encephalopathy, and Acute (on Chronic) Brain Injury

  2019cited by this paper
• Neurofilaments as biomarkers in neurological disorders

  2018cited by this paper
• Clinical scenarios for the use of S100β as a marker of hepatic encephalopathy.

  2016cited by this paper
• Neurofilament Subunits are Integral Components of Synapses and Modulate Neurotransmission and Behavior In Vivo

  2015cited by this paper
• Interferon gamma, interleukin-6, and -17a levels were correlated with minimal hepatic encephalopathy in HBV patients

  2015cited by this paper
• Minimal hepatic encephalopathy and critical flicker frequency are associated with survival of patients with cirrhosis.

  2015cited by this paper
• The global burden of liver disease: The major impact of China

  2014cited by this paper
• Psychometric hepatic encephalopathy score for diagnosis of minimal hepatic encephalopathy in China.

  2013cited by this paper
• Ammonia toxicity to the brain

  2013cited by this paper
• Evidence of persistent cognitive impairment after resolution of overt hepatic encephalopathy.

  2011cited by this paper
• Persistence of cognitive impairment after resolution of overt hepatic encephalopathy.

  2010cited by this paper
• Hyperammonemia induces neuroinflammation that contributes to cognitive impairment in rats with hepatic encephalopathy.

  2010cited by this paper
• Impact of preoperative overt hepatic encephalopathy on neurocognitive function after liver transplantation

  2009cited by this paper
• IL-6 and IL-18 in Blood May Discriminate Cirrhotic Patients With and Without Minimal Hepatic Encephalopathy

  2009cited by this paper
• Perioperative Neurological Complications After Liver Transplantation are Best Predicted by Pre-transplant Hepatic Encephalopathy

  2008cited by this paper
• Brain metabolism of 13N‐ammonia during acute hepatic encephalopathy in cirrhosis measured by positron emission tomography

  2006cited by this paper
• Incomplete improvement of visuo‐motor deficits in patients with minimal hepatic encephalopathy after liver transplantation

  2004cited by this paper
• [Liver cirrhosis].

  1989cited by this paper

• Serum Neurodegenerative Biomarkers for the Early Diagnosis of Minimal Hepatic Encephalopathy

  2026cites this paper
• Neurofilament Light Chains in Serum Predict Post—Transjugular Intrahepatic Portosystemic Shunt Hepatic Encephalopathy

  2025cites this paper